Fennec Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patient…

Biotechnology
US, Research Triangle Park [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of FENC's Analysis
CIK: 1211583 CUSIP: 31447P100 ISIN: CA31447P1009 LEI: - UEI: -
Secondary Listings
FENC has no secondary listings inside our databases.